Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
University of Oulu Maps Real‑Time Brain Waste Clearance During Sleep
Scientists at the University of Oulu have deployed an ultrafast MRI method to watch water and ion movement in the brain while participants sleep, showing accelerated vasomotor pulses that boost waste clearance. The breakthrough offers a non‑invasive window into sleep‑related brain health, a key focus for biohackers seeking optimal recovery.
April 8, 2026 – The Week in Health Care News
The week’s health‑care news was dominated by a wave of anti‑abortion legislation, with Ohio doctors signing a letter against more than 150 extremist bills and Mississippi moving to criminalize abortion pills. The Trump administration faced scrutiny as Medicaid cuts threaten...
11 Hospitals, Health Systems Adding New C-Suite Roles in 2026
In 2024, eleven hospitals and health systems announced inaugural C‑suite roles slated to begin in 2026, covering positions such as chief clinical officer, chief health AI transformation officer, chief nursing executive, and chief digital and information officer. The appointments span...
How Can More Efficient Data Sharing Improve Patient Care Plans?
Health Information Exchanges (HIEs) let clinicians, pharmacists and patients securely share vital medical data electronically, boosting care speed, safety and cost efficiency. Yet each HIE often uses its own data format, leading to fragmented records when patients see multiple providers....
Forecasting Protein Aggregation with an Improved Algorithm
Scientists at the Autonomous University of Barcelona have released the fourth generation of their protein‑aggregation forecasting algorithm, which leverages AlphaFold structural data and molecular‑dynamics simulations. The tool lets users evaluate aggregation risk, explore mutations, scan protein families, and assess pH...
Trump’s New Pharmaceutical Tariffs Will Hit Small Drugmakers Hardest
The Trump administration revived pharmaceutical tariffs, imposing a 100% base duty on imported patented drugs and their active ingredients. While generic medicines and UK imports are exempt, firms with Most Favored Nation (MFN) agreements—such as Pfizer and Eli Lilly—are shielded, and...
Insurer Must Defend Doctor Accused of ‘Fertility Fraud’
A Connecticut appellate court reversed a lower‑court decision, requiring medical‑malpractice insurer Integris Insurance to cover the defense costs of Dr. Narendra Tohan, accused of using his own sperm in IVF procedures without patient consent. The court found the insurer had...
Science-Backed Vaccines Protect Kids and Save Futures
My all time favorite ingredient of vaccines? SCIENCE. Follow the evidence. It is the safest place to be and the best way to protect your kids. Vaccinate your babies. Vaccines save lives and futures.
FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing Opioid Pain Relievers or Medicines to Treat Opioid...
The FDA has mandated that manufacturers add naloxone guidance to the prescribing information for all opioid pain relievers and medications for opioid use disorder (OUD). Health‑care professionals must now discuss naloxone availability with every patient receiving an opioid prescription or...
Some Epic Health Systems Now Connect to SSA Through TEFCA
Epic Systems announced that health organizations using its EHR can now exchange patient records with the Social Security Administration instantly through the Trusted Exchange Framework and Common Agreement (TEFCA). The move adds five health systems—AltaMed, Citizen Potawatomi Nation Health Services,...
Bayesian Statistical Analysis (BSA) Demonstration Project
The FDA’s CDER Center for Clinical Trial Innovation (C3TI) has launched a Bayesian Statistical Analysis (BSA) demonstration project to encourage the use of Bayesian methods in simple phase 3 trials. The program lets sponsors collaborate with FDA statisticians to apply Bayesian...
UNC Health, UNC-Chapel Hill Debut Platform for AI Development
UNC-Chapel Hill and UNC Health have launched SHIRE, a secure cloud‑based platform that lets credentialed researchers access curated electronic health record data for AI development. The system, built by the NC TraCS Informatics team, offers scalable computing power while maintaining...
FDA Warns About Risks of Dental Problems Associated with Buprenorphine Medicines Dissolved in the Mouth to Treat Opioid Use Disorder...
The FDA has issued a new safety warning that buprenorphine tablets and films dissolved under the tongue or against the cheek can cause dental problems such as cavities, abscesses, and even tooth loss. The alert applies to both single‑ingredient buprenorphine...
Imaging Delays Surge as Radiology Workforce Hits Limits: Study
Imaging interpretation turnaround times for Medicare fee‑for‑service patients have more than doubled between 2014 and 2023, rising from roughly 2.2 hours to 4.6 hours on average. The slowdown is especially acute for advanced modalities, with CT scans experiencing a 318%...
FDA Issues Series of Guidances Under Drug Competition Action Plan
The FDA released three new guidances under its Drug Competition Action Plan to streamline generic drug reviews. A final guidance clarifies the use of Information Requests and Discipline Review Letters, a revised draft updates procedures for aligning ANDA labeling with...
Approved First Generic for Apokyn Injection Cartridges Requires Separately Packaged Pen
The FDA approved Sage Chemical’s generic apomorphine hydrochloride cartridges, the first generic version of Apokyn for treating "off" episodes in advanced Parkinson’s disease. The generic cartridges work only with the proprietary Apokyn Pen, which must be obtained separately through specialty...
FDA Announces Evusheld Is Not Currently Authorized for Emergency Use in the U.S.
The FDA revised Evusheld's Emergency Use Authorization on Jan. 26, 2023, limiting its use to situations where susceptible SARS‑CoV‑2 variants comprise 90% or less of national cases. With current CDC data showing over 90% of circulating variants are resistant, Evusheld...
FDA Updates Sotrovimab Emergency Use Authorization
The U.S. Food and Drug Administration revoked the Emergency Use Authorization for sotrovimab on April 5, 2022, after CDC data showed the Omicron BA.2 sub‑variant accounted for more than 50 % of cases in every HHS region. Earlier in the year the agency...
Advancing Novel Surrogate Endpoints For Rare Disease Drug Development Workshop - 05/18/2026
The FDA is hosting a virtual workshop on May 18, 2026 to advance novel surrogate endpoints for rare disease drug development. The event is part of the Rare Disease Endpoint Advancement (RDEA) Pilot Program, mandated by PDUFA VII and FDORA, which requires up...
FDA Works to Protect Consumers From Potentially Harmful OTC Skin Lightening Products
The U.S. Food and Drug Administration issued warning letters to twelve companies for selling over‑the‑counter skin‑lightening products that contain hydroquinone, an ingredient not approved for OTC use. The agency highlighted serious adverse events such as rashes, facial swelling, and permanent...
New Nasal Flu Vaccine Shows Promise in Mice
Researchers at Georgia State University have engineered an intranasal influenza vaccine that uses cell‑derived extracellular vesicles (EVs) to display inverted hemagglutinin (HA) proteins. The upside‑down HA exposes the conserved stalk region while masking the variable head, prompting cross‑protective immunity. In...
HeyDonto AI Technology Closes $20M Seed Round at $200M Valuation to Scale Conduit — The Dental Interoperability Exchange
HeyDonto AI Technology announced a $20 million seed round that values the company at $200 million. The capital will be used to scale Conduit, its AI‑powered dental interoperability platform that links dental practice systems with medical EHRs, payers and patient apps. Conduit...
Modifying Gut Microbiome Boosts Memory, Slows Dementia
As a medical school professor, I teach that the gut-brain axis is real. But even I was surprised by this. A review in Nutrition Research confirmed: reshaping the gut microbiome can enhance cognitive performance and slow dementia progression. Key findings across multiple...
Genomics Predicts Individual Weight Loss From GLP‑1 Drugs
Genomics of GLP-1 drug response and side effects With genomic and demographic data it's possible to predict magnitude of weight loss response @23andMe https://t.co/iAS2Fjjxig https://t.co/AXsWnZw2Ub
Patients Are Using Chatbots to Fight Medical Bills, With Mixed Results
Patients are increasingly turning to free AI chatbots like Claude and ChatGPT to dispute medical bills, exemplified by a couple who used Claude to challenge a $22,604 emergency‑room charge. The American Hospital Association has flagged this growing DIY trend as...
Merck Adjusts Its Vaccine Supply Deal in China; Soleno Withdraws EU Application
Merck and its Chinese partner Zhifei have revised their COVID‑19 vaccine supply agreement, lowering the committed volume and adding a flexible delivery schedule to reflect waning demand. The updated contract preserves Zhifei’s exclusive distribution rights but shifts risk back to...
Jeito Capital, Prominent Biotech Investor, Raises $1.2B for Next Fund
Jeito Capital announced the close of its Jeito II fund, raising €1 billion (about $1.2 billion) – the largest capital raise ever for an independent European biopharma fund. The fund will back 15‑20 clinical‑stage drugmakers, allocating up to €150 million ($162 million) per company across...
The Company Helping Paralyzed People Move And Thrive Again - EP 64 Dave Marver
In this episode, Dave Marver, CEO of Onward, explains how the company’s spinal cord stimulation platform, ArcIM, combined with a minimally invasive epidural brain‑computer interface (BCI), can translate a patient’s movement intentions into real‑time leg stimulation, enabling paralyzed individuals to...
Quince Therapeutics: Today’s NASDAQ Wunderkinder Spotlight
And, of course, the day wouldn't be complete without a NASDAQ wunderkinder. Today's is Quince Therapeutics: https://t.co/SN5w5K1UCd
Skilled Nursing Facilities Get a Proposed 2.4% Increase
The Centers for Medicare & Medicaid Services (CMS) has proposed a 2.4% increase to the Skilled Nursing Facility Prospective Payment System for fiscal year 2027, derived from a 3.2% market basket adjustment offset by a 0.8% productivity factor. Facilities that...
Rune Labs Launches StrivePD Guardian, an AI Companion for Parkinson’s Disease Powered by Claude
Rune Labs has introduced StrivePD Guardian, an AI‑powered companion for Parkinson’s disease that operates as an agentic system. The app, built on Anthropic’s Claude model, routes patient queries to specialized sub‑agents such as a Medication Assistant and PD Coach, while...
Gilead Takes Another Big Swing at Expanding Beyond HIV
Gilead Sciences has earmarked roughly $11 billion this year for three strategic acquisitions aimed at strengthening its cancer and immunology pipelines. The moves signal a decisive pivot away from its historic reliance on HIV therapeutics toward broader biotech markets. The targeted...
AI Uncovers Significant Misdiagnoses in Carcinoma Type, Study Shows
Caris Life Sciences published a JAMA Network Open study showing its GPSai algorithm identified misdiagnoses in lung squamous cell carcinoma (SCC). Among nearly 4,000 cases, 123 (3.1%) were re‑classified as metastases from other primary sites. The AI model combined molecular,...
New Light Shed on Who Benefits Most From Weight-Loss Jabs
A new study published in Nature examined 15,000 people who used GLP‑1 weight‑loss drugs such as Wegovy and Mounjaro and found that two genetic variants linked to appetite and digestion significantly boost weight loss and increase nausea risk. Carriers of...
Greenway Health Works With Customers to Implement Agentic AI Features
Greenway Health has launched Novare, an agentic‑AI‑powered EHR platform that rebuilds its clinical, revenue‑cycle and patient‑engagement services from the ground up. The system offers ambient note‑taking, voice‑activated chart search, intelligent coding, automated prior authorizations and real‑time benefit checks, aiming to...
Readers Write: Chatbots Are Repeating a Familiar Healthcare Mistake
Reader commentary highlights that AI‑driven chatbots are echoing long‑standing digital‑health missteps. Without clear federal or state mandates, health systems risk deploying fragmented tools that compromise patient safety and data security. The author urges providers to view chatbots as integral components...
Genomic Drivers of Venetoclax Resistance in T(11;14) Myeloma
Genomic mechanisms of resistance to venetoclax in multiple myeloma with t(11;14)(CCND1;IGH) [Apr 2, 2026] @MKaddouraMD et al. @lbaughn @BloodPortfolio https://t.co/qmI6giPG6K #mmsm #PrecisionMedicine https://t.co/hpwUcavTg9
Peer-Led Storytelling in Adolescent Substance Use Prevention
A recent study of the school‑based "Ignite & Engage" program, run by the Midwest recovery group Rise Together, surveyed over 10,000 middle‑ and high‑school students who attended peer‑led recovery storytelling assemblies. More than half of students with prior substance‑use experience reported a...
New Gene Therapy May Help Protect the Hearts of Patients with Friedreich's Ataxia
Lexeo Therapeutics reported early-phase results for its investigational gene therapy AAVrh.10hFXN (LX2006) in Friedreich’s ataxia–associated cardiomyopathy. In a phase 1 trial of 17 adults, a single intravenous infusion was well tolerated and produced signals of cardiac improvement, while neurological scores remained...
ICHRAs, a Growth Opportunity for Insurers, Face Uphill Battle
Individual Coverage Health Reimbursement Arrangements (ICHRAs) are gaining traction as insurers search for growth amid stagnant commercial plan enrollment. Adoption jumped 19% from 2024 to 2025, with a 34% surge among large employers, prompting payers like Centene and Oscar to...
Wildflower Once Used to Treat Wounds and Sore Throats Shows Promise in Fighting Dangerous Superbugs
Researchers at Irish universities have demonstrated that extracts from the wildflower tormentil (Potentilla erecta) possess strong antimicrobial activity against multidrug‑resistant bacteria, including strains that cause pneumonia and urinary‑tract infections. The study identified ellagic acid and agrimoniin as the key compounds...
Never-Married Individuals Face 70% Higher Cancer Risk
Does never-married raise the risk of developing cancer? That what a new report says with a incidence rate ratio (IRR) of ~1.70 in both men and women. https://t.co/lz3wgagNRA https://t.co/ymwPqXT19x
Brokers Poised to End the Healthcare Heist
Louis C. Bernardi argues that the U.S. health‑benefits system persists because it exploits human aversion to change, not because it is efficient. Brokers and consultants, conditioned by renewal cycles and carrier‑centric products, often reinforce this inertia, allowing employers to accept...
Frazier Healthcare Partners Taps Randy Hyun for Exec in Residence
Frazier Healthcare Partners has appointed Randy Hyun as an executive in residence, a role designed to scout and evaluate new investment opportunities. Hyun will concentrate specifically on the pharmacy services sector, leveraging his industry experience to identify high‑growth targets. The...
Payer Denials and Prior Authorization Delays Are Top RCM Concerns
A recent HFMA/Guidehouse survey finds payer denials and prior‑authorization delays are the top revenue‑cycle concerns for hospitals. While 78% of respondents already use AI automation for manual RCM tasks, 59% have not applied AI to the revenue cycle itself. Denials...
Closing Care Gaps with Wearables
American College of Cardiology (ACC) Chief Innovation Officer Dr. Ami Bhatt warned that wearable devices that flag disease risk must do more than alert users—they need to steer patients toward appropriate care pathways. As wearables become capable of detecting early...
AI Can Deliver Full Medical School Curriculum
On the future of medical education…. An “AI generated medical school” with “400 lectures for all four years — Over 1200 case studies, 16,000 figures and 20,000 quiz questions… a full curriculum map as well to track your progress…”...
RFK Jr. Pushes to Overturn Peptide Ban, Officials Dispute Claims
RFK Jr. May Reverse a Peptide Ban He Calls “Illegal.” Former FDA Officials Say He Mischaracterized Their Work. https://t.co/glqreTHvKA https://t.co/Vi4OTryX3p
Pemivibart Shows Safety, Prevents COVID-19 in CLL Subset in Phase 3 CANOPY Trial
A phase 3 CANOPY subset analysis evaluated pemivibart, a recombinant IgG1 monoclonal antibody, for pre‑exposure COVID‑19 prophylaxis in patients with chronic lymphocytic leukemia (CLL). Among 29 CLL participants, none developed symptomatic SARS‑CoV‑2 infection over a 180‑day follow‑up, and the safety profile...
Inside the Talkspace-Universal Health Services Deal
Talkspace, the pandemic‑era teletherapy platform, agreed to be acquired by Universal Health Services (UHS) in a deal valued at roughly $600 million in cash and stock. The transaction gives UHS a digital mental‑health capability across its 400‑plus hospitals and outpatient centers....